Curcumin and cancer: an "old-age" disease with an "age-old" solution.
By P. Anand, C. Sundaram, Sonia Jhurani, A. Kunnumakkara, Bharat B. Aggarwal. Cancer Letters, 2008
1,136 citations recorded by the source corpus.
Subfields: Molecular Biology, Molecular Medicine
View Paper: https://www.semanticscholar.org/paper/8aa33e610cff261705afc38069afdbf9276b6aab
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- Bharat B. Aggarwal
- Subash C. Gupta
- K. Harikumar
- Bokyung Sung
- P. Anand
- S. Prasad
- A. Kunnumakkara
- J. Kim
In Molecular Medicine
- Bharat B. Aggarwal
- S. Prasad
- Bokyung Sung
- A. Kunnumakkara
- P. Anand
- K. Harikumar
- Subash C. Gupta
- B. Kocaadam
Citations in the corpus
- Potential Therapeutic Effects of Curcumin, the Anti-inflammatory Agent, Against Neurodegenerative, Cardiovascular, Pulmonary, Metabolic, Autoimmune and Neoplastic Diseases (2008, background): “…well as in vivo studies demonstrated that curcumin can inhibit the growth of various cancer cells from different organs including blood, brain, breast, gastrointestinal system, head and neck, liver, pancreas, colon, prostate, ovary and skin cancers (Anand et al., 2008) (Kunnumakkara et al., 2008).”
- Curcumin and Cancer (2019, background): “It also upregulated the proapoptotic protein BIM [50,51].”
- Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. (2014, background): “It should be mentioned that main drawbacks of such monotargeted therapies are the ineffectiveness due to induction of drug resistancy and frequently observed severe side effects [17,21].”
- Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals (2010, background): “It is now clear that cancerous phenotypes result from the dysregulation of more than 500 genes at multiple steps in cell signaling pathways [19,20].”
- Nanocurcumin: A Promising Candidate for Therapeutic Applications (2020, background): “…substitutions in the diferuloylmethane chemical structure (which is responsible for yellow coloration), demethoxycurcumin, bisdemethoxycurcumin, and cyclocurcumin (Figure 1) are responsible for many biological and pharmacological differential activities of these compounds (Anand et al. , 2008).”
- Cancer is a Preventable Disease that Requires Major Lifestyle Changes (2008, background): “A detailed description of curcumin and its anticancer properties can be found in one of our recent reviews (79).”
- Curcumin, an active component of turmeric (Curcuma longa), and its effects on health (2017, background): “It is stated that, thanks to these effects of curcumin, it is effective for decreasing or preventing various cancer types including multiple myeloma and colon, pancreas, breast, prostates, and lung cancers (Anand et al., 2008; Devassy et al., 2015).”
- Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases (2017, background): “…of multiple cell signalling pathways linked to different chronic diseases, which strongly suggest that it is a potent multi-targeted polyphenol (Anand et al., 2008; Kunnumakkara et al., 2008; Ravindran et al., 2009; Goel and Aggarwal, 2010; Hasima and Aggarwal, 2012; Aggarwal et al., 2015;…”
- Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. (2008, background): “[11] Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB.”